nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—TNNC1—connective tissue—Graves' disease	0.0293	0.0539	CbGeAlD
Bepridil—PDE1B—adipose tissue—Graves' disease	0.0235	0.0432	CbGeAlD
Bepridil—TNNC1—pituitary gland—Graves' disease	0.0226	0.0416	CbGeAlD
Bepridil—TNNC1—adipose tissue—Graves' disease	0.0225	0.0414	CbGeAlD
Bepridil—PDE1B—thyroid gland—Graves' disease	0.0203	0.0374	CbGeAlD
Bepridil—PDE1A—adipose tissue—Graves' disease	0.0197	0.0362	CbGeAlD
Bepridil—TNNC1—thyroid gland—Graves' disease	0.0195	0.0358	CbGeAlD
Bepridil—CACNA2D2—pituitary gland—Graves' disease	0.019	0.035	CbGeAlD
Bepridil—KCNQ1—pituitary gland—Graves' disease	0.0184	0.0338	CbGeAlD
Bepridil—KCNQ1—adipose tissue—Graves' disease	0.0183	0.0336	CbGeAlD
Bepridil—PDE1A—thyroid gland—Graves' disease	0.017	0.0313	CbGeAlD
Bepridil—CACNA2D2—thyroid gland—Graves' disease	0.0164	0.0301	CbGeAlD
Bepridil—KCNQ1—thyroid gland—Graves' disease	0.0158	0.0291	CbGeAlD
Bepridil—CACNA1H—pituitary gland—Graves' disease	0.0154	0.0284	CbGeAlD
Bepridil—CACNA1C—connective tissue—Graves' disease	0.0153	0.028	CbGeAlD
Bepridil—Drowsiness—Methimazole—Graves' disease	0.0147	0.0733	CcSEcCtD
Bepridil—CACNA1H—thyroid gland—Graves' disease	0.0133	0.0244	CbGeAlD
Bepridil—CALM3—eye—Graves' disease	0.0133	0.0244	CbGeAlD
Bepridil—CACNA1D—pituitary gland—Graves' disease	0.0127	0.0234	CbGeAlD
Bepridil—Drowsiness—Propylthiouracil—Graves' disease	0.0125	0.0623	CcSEcCtD
Bepridil—ATP1A1—eye—Graves' disease	0.0118	0.0217	CbGeAlD
Bepridil—CACNA1C—pituitary gland—Graves' disease	0.0117	0.0216	CbGeAlD
Bepridil—CACNA1C—adipose tissue—Graves' disease	0.0117	0.0215	CbGeAlD
Bepridil—ATP1A1—connective tissue—Graves' disease	0.0114	0.0209	CbGeAlD
Bepridil—CACNA1D—thyroid gland—Graves' disease	0.011	0.0202	CbGeAlD
Bepridil—CALM2—eye—Graves' disease	0.0104	0.0191	CbGeAlD
Bepridil—CALM1—eye—Graves' disease	0.0104	0.0191	CbGeAlD
Bepridil—Vertigo—Methimazole—Graves' disease	0.0103	0.0515	CcSEcCtD
Bepridil—CALM2—connective tissue—Graves' disease	0.01	0.0184	CbGeAlD
Bepridil—CALM1—connective tissue—Graves' disease	0.00999	0.0184	CbGeAlD
Bepridil—CALM3—pituitary gland—Graves' disease	0.00984	0.0181	CbGeAlD
Bepridil—CALM3—adipose tissue—Graves' disease	0.0098	0.018	CbGeAlD
Bepridil—Myalgia—Methimazole—Graves' disease	0.00976	0.0488	CcSEcCtD
Bepridil—Oedema—Methimazole—Graves' disease	0.00935	0.0467	CcSEcCtD
Bepridil—ATP1A1—pituitary gland—Graves' disease	0.00878	0.0161	CbGeAlD
Bepridil—Vertigo—Propylthiouracil—Graves' disease	0.00875	0.0438	CcSEcCtD
Bepridil—ATP1A1—adipose tissue—Graves' disease	0.00874	0.0161	CbGeAlD
Bepridil—Musculoskeletal discomfort—Methimazole—Graves' disease	0.00852	0.0426	CcSEcCtD
Bepridil—CALM3—thyroid gland—Graves' disease	0.00848	0.0156	CbGeAlD
Bepridil—Paraesthesia—Methimazole—Graves' disease	0.0084	0.042	CcSEcCtD
Bepridil—Somnolence—Methimazole—Graves' disease	0.00831	0.0416	CcSEcCtD
Bepridil—Myalgia—Propylthiouracil—Graves' disease	0.0083	0.0415	CcSEcCtD
Bepridil—Dyspepsia—Methimazole—Graves' disease	0.00823	0.0412	CcSEcCtD
Bepridil—Oedema—Propylthiouracil—Graves' disease	0.00795	0.0398	CcSEcCtD
Bepridil—CALM2—pituitary gland—Graves' disease	0.00773	0.0142	CbGeAlD
Bepridil—CALM2—adipose tissue—Graves' disease	0.0077	0.0142	CbGeAlD
Bepridil—CALM1—pituitary gland—Graves' disease	0.00769	0.0141	CbGeAlD
Bepridil—CALM1—adipose tissue—Graves' disease	0.00766	0.0141	CbGeAlD
Bepridil—ATP1A1—thyroid gland—Graves' disease	0.00757	0.0139	CbGeAlD
Bepridil—Body temperature increased—Methimazole—Graves' disease	0.00739	0.037	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.00725	0.0362	CcSEcCtD
Bepridil—Paraesthesia—Propylthiouracil—Graves' disease	0.00714	0.0357	CcSEcCtD
Bepridil—Somnolence—Propylthiouracil—Graves' disease	0.00707	0.0353	CcSEcCtD
Bepridil—KCNH2—pituitary gland—Graves' disease	0.007	0.0129	CbGeAlD
Bepridil—Dyspepsia—Propylthiouracil—Graves' disease	0.007	0.035	CcSEcCtD
Bepridil—CALM2—thyroid gland—Graves' disease	0.00666	0.0123	CbGeAlD
Bepridil—CALM1—thyroid gland—Graves' disease	0.00663	0.0122	CbGeAlD
Bepridil—Body temperature increased—Propylthiouracil—Graves' disease	0.00629	0.0314	CcSEcCtD
Bepridil—Rash—Methimazole—Graves' disease	0.0059	0.0295	CcSEcCtD
Bepridil—Dermatitis—Methimazole—Graves' disease	0.00589	0.0294	CcSEcCtD
Bepridil—Headache—Methimazole—Graves' disease	0.00586	0.0293	CcSEcCtD
Bepridil—Nausea—Methimazole—Graves' disease	0.00556	0.0278	CcSEcCtD
Bepridil—Rash—Propylthiouracil—Graves' disease	0.00501	0.0251	CcSEcCtD
Bepridil—Dermatitis—Propylthiouracil—Graves' disease	0.00501	0.025	CcSEcCtD
Bepridil—Headache—Propylthiouracil—Graves' disease	0.00498	0.0249	CcSEcCtD
Bepridil—Nausea—Propylthiouracil—Graves' disease	0.00472	0.0236	CcSEcCtD
Bepridil—ABCB1—pituitary gland—Graves' disease	0.00307	0.00565	CbGeAlD
Bepridil—ABCB1—adipose tissue—Graves' disease	0.00306	0.00562	CbGeAlD
Bepridil—ABCB1—thyroid gland—Graves' disease	0.00265	0.00487	CbGeAlD
Bepridil—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Graves' disease	0.000866	0.00338	CbGpPWpGaD
Bepridil—CALM3—Carbohydrate metabolism—B3GNT2—Graves' disease	0.00086	0.00336	CbGpPWpGaD
Bepridil—CALM2—IFN-gamma pathway—IL1B—Graves' disease	0.000843	0.00329	CbGpPWpGaD
Bepridil—CALM1—IFN-gamma pathway—IL1B—Graves' disease	0.000843	0.00329	CbGpPWpGaD
Bepridil—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Graves' disease	0.000838	0.00327	CbGpPWpGaD
Bepridil—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Graves' disease	0.000838	0.00327	CbGpPWpGaD
Bepridil—CALM2—Carbohydrate metabolism—B3GNT2—Graves' disease	0.000832	0.00325	CbGpPWpGaD
Bepridil—CALM1—Carbohydrate metabolism—B3GNT2—Graves' disease	0.000832	0.00325	CbGpPWpGaD
Bepridil—ABCB1—Allograft Rejection—HLA-DQB1—Graves' disease	0.00082	0.0032	CbGpPWpGaD
Bepridil—CACNA2D2—Metabolism—B3GNT2—Graves' disease	0.000812	0.00317	CbGpPWpGaD
Bepridil—PDE1A—Innate Immune System—HLA-E—Graves' disease	0.000766	0.00299	CbGpPWpGaD
Bepridil—CALM3—DAP12 signaling—HLA-E—Graves' disease	0.00076	0.00297	CbGpPWpGaD
Bepridil—ABCB1—Allograft Rejection—HLA-B—Graves' disease	0.000736	0.00287	CbGpPWpGaD
Bepridil—CALM1—DAP12 signaling—HLA-E—Graves' disease	0.000735	0.00287	CbGpPWpGaD
Bepridil—CALM2—DAP12 signaling—HLA-E—Graves' disease	0.000735	0.00287	CbGpPWpGaD
Bepridil—PDE1A—GPCR downstream signaling—TSHR—Graves' disease	0.000727	0.00284	CbGpPWpGaD
Bepridil—ABCB1—Allograft Rejection—FASLG—Graves' disease	0.00072	0.00281	CbGpPWpGaD
Bepridil—CALM3—DAP12 interactions—HLA-E—Graves' disease	0.000715	0.00279	CbGpPWpGaD
Bepridil—PDE1B—Innate Immune System—HLA-E—Graves' disease	0.000701	0.00274	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—GC—Graves' disease	0.000696	0.00272	CbGpPWpGaD
Bepridil—ABCB1—Allograft Rejection—FAS—Graves' disease	0.000694	0.00271	CbGpPWpGaD
Bepridil—CALM3—Downstream signaling in naïve CD8+ T cells—IFNG—Graves' disease	0.000694	0.00271	CbGpPWpGaD
Bepridil—CALM2—DAP12 interactions—HLA-E—Graves' disease	0.000692	0.0027	CbGpPWpGaD
Bepridil—CALM1—DAP12 interactions—HLA-E—Graves' disease	0.000692	0.0027	CbGpPWpGaD
Bepridil—KCNH2—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000691	0.0027	CbGpPWpGaD
Bepridil—ABCB1—Allograft Rejection—IL2RA—Graves' disease	0.00069	0.00269	CbGpPWpGaD
Bepridil—ABCB1—Allograft Rejection—HLA-A—Graves' disease	0.000682	0.00266	CbGpPWpGaD
Bepridil—PDE1A—Disease—B3GNT2—Graves' disease	0.000672	0.00262	CbGpPWpGaD
Bepridil—CALM2—Downstream signaling in naïve CD8+ T cells—IFNG—Graves' disease	0.000671	0.00262	CbGpPWpGaD
Bepridil—CALM1—Downstream signaling in naïve CD8+ T cells—IFNG—Graves' disease	0.000671	0.00262	CbGpPWpGaD
Bepridil—PDE1B—GPCR downstream signaling—TSHR—Graves' disease	0.000665	0.0026	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—TSHR—Graves' disease	0.00066	0.00258	CbGpPWpGaD
Bepridil—ABCB1—Allograft Rejection—HLA-DRB1—Graves' disease	0.000623	0.00243	CbGpPWpGaD
Bepridil—PDE1B—Disease—B3GNT2—Graves' disease	0.000615	0.0024	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—GC—Graves' disease	0.000611	0.00239	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—TSHR—Graves' disease	0.000604	0.00236	CbGpPWpGaD
Bepridil—PDE1A—Hemostasis—IL2RA—Graves' disease	0.000568	0.00222	CbGpPWpGaD
Bepridil—PDE1A—Immune System—IFIH1—Graves' disease	0.000567	0.00221	CbGpPWpGaD
Bepridil—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.000561	0.00219	CbGpPWpGaD
Bepridil—PDE1A—Innate Immune System—HLA-B—Graves' disease	0.000546	0.00213	CbGpPWpGaD
Bepridil—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.000542	0.00212	CbGpPWpGaD
Bepridil—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.000542	0.00212	CbGpPWpGaD
Bepridil—CALM3—Alzheimers Disease—IL1B—Graves' disease	0.000536	0.00209	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—B3GNT2—Graves' disease	0.000527	0.00206	CbGpPWpGaD
Bepridil—PDE1B—Hemostasis—IL2RA—Graves' disease	0.00052	0.00203	CbGpPWpGaD
Bepridil—PDE1B—Immune System—IFIH1—Graves' disease	0.000519	0.00203	CbGpPWpGaD
Bepridil—CALM1—Alzheimers Disease—IL1B—Graves' disease	0.000518	0.00202	CbGpPWpGaD
Bepridil—CALM2—Alzheimers Disease—IL1B—Graves' disease	0.000518	0.00202	CbGpPWpGaD
Bepridil—CALM3—DAP12 interactions—HLA-B—Graves' disease	0.00051	0.00199	CbGpPWpGaD
Bepridil—CALM2—Cardiac Hypertrophic Response—TNF—Graves' disease	0.000502	0.00196	CbGpPWpGaD
Bepridil—CALM1—Cardiac Hypertrophic Response—TNF—Graves' disease	0.000502	0.00196	CbGpPWpGaD
Bepridil—KCNH2—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000501	0.00196	CbGpPWpGaD
Bepridil—PDE1B—Innate Immune System—HLA-B—Graves' disease	0.000499	0.00195	CbGpPWpGaD
Bepridil—CALM2—DAP12 interactions—HLA-B—Graves' disease	0.000493	0.00192	CbGpPWpGaD
Bepridil—CALM1—DAP12 interactions—HLA-B—Graves' disease	0.000493	0.00192	CbGpPWpGaD
Bepridil—PDE1A—GPCR downstream signaling—CXCL10—Graves' disease	0.00047	0.00183	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—B3GNT2—Graves' disease	0.000463	0.00181	CbGpPWpGaD
Bepridil—ABCB1—Allograft Rejection—IFNG—Graves' disease	0.000455	0.00178	CbGpPWpGaD
Bepridil—CALM3—Downstream signaling in naïve CD8+ T cells—TNF—Graves' disease	0.000449	0.00175	CbGpPWpGaD
Bepridil—PDE1A—Immune System—HLA-E—Graves' disease	0.000446	0.00174	CbGpPWpGaD
Bepridil—PDE1A—Immune System—CD40—Graves' disease	0.000436	0.0017	CbGpPWpGaD
Bepridil—CALM2—Downstream signaling in naïve CD8+ T cells—TNF—Graves' disease	0.000434	0.0017	CbGpPWpGaD
Bepridil—CALM1—Downstream signaling in naïve CD8+ T cells—TNF—Graves' disease	0.000434	0.0017	CbGpPWpGaD
Bepridil—PDE1A—Immune System—CTLA4—Graves' disease	0.00043	0.00168	CbGpPWpGaD
Bepridil—PDE1B—GPCR downstream signaling—CXCL10—Graves' disease	0.00043	0.00168	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—CXCL10—Graves' disease	0.000427	0.00167	CbGpPWpGaD
Bepridil—PDE1B—Immune System—HLA-E—Graves' disease	0.000408	0.00159	CbGpPWpGaD
Bepridil—ABCB1—Allograft Rejection—IL1B—Graves' disease	0.000406	0.00159	CbGpPWpGaD
Bepridil—ABCB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000405	0.00158	CbGpPWpGaD
Bepridil—CALM3—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.0004	0.00156	CbGpPWpGaD
Bepridil—PDE1B—Immune System—CD40—Graves' disease	0.000399	0.00156	CbGpPWpGaD
Bepridil—PDE1B—Immune System—CTLA4—Graves' disease	0.000393	0.00153	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—CXCL10—Graves' disease	0.00039	0.00152	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—TSHR—Graves' disease	0.00039	0.00152	CbGpPWpGaD
Bepridil—CALM3—Alzheimers Disease—TNF—Graves' disease	0.000389	0.00152	CbGpPWpGaD
Bepridil—CALM1—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000387	0.00151	CbGpPWpGaD
Bepridil—CALM2—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000387	0.00151	CbGpPWpGaD
Bepridil—CALM2—Alzheimers Disease—TNF—Graves' disease	0.000376	0.00147	CbGpPWpGaD
Bepridil—CALM1—Alzheimers Disease—TNF—Graves' disease	0.000376	0.00147	CbGpPWpGaD
Bepridil—PDE1A—GPCR downstream signaling—IL2RA—Graves' disease	0.000359	0.0014	CbGpPWpGaD
Bepridil—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	0.000358	0.0014	CbGpPWpGaD
Bepridil—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	0.000358	0.0014	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—TSHR—Graves' disease	0.000357	0.00139	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000355	0.00139	CbGpPWpGaD
Bepridil—PDE1A—Immune System—HLA-DQB1—Graves' disease	0.000354	0.00138	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—IFIH1—Graves' disease	0.000353	0.00138	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000342	0.00134	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—IFIH1—Graves' disease	0.000342	0.00133	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—IFIH1—Graves' disease	0.000342	0.00133	CbGpPWpGaD
Bepridil—CACNA1H—Developmental Biology—TNF—Graves' disease	0.000336	0.00131	CbGpPWpGaD
Bepridil—PDE1A—Immune System—CD8A—Graves' disease	0.000331	0.00129	CbGpPWpGaD
Bepridil—PDE1B—GPCR downstream signaling—IL2RA—Graves' disease	0.000328	0.00128	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—IL2RA—Graves' disease	0.000326	0.00127	CbGpPWpGaD
Bepridil—PDE1A—Innate Immune System—CD4—Graves' disease	0.000326	0.00127	CbGpPWpGaD
Bepridil—PDE1B—Immune System—HLA-DQB1—Graves' disease	0.000324	0.00126	CbGpPWpGaD
Bepridil—PDE1A—Immune System—HLA-B—Graves' disease	0.000318	0.00124	CbGpPWpGaD
Bepridil—CALM3—Myometrial Relaxation and Contraction Pathways—IL1B—Graves' disease	0.000312	0.00122	CbGpPWpGaD
Bepridil—PDE1B—Immune System—CD8A—Graves' disease	0.000302	0.00118	CbGpPWpGaD
Bepridil—CALM1—Myometrial Relaxation and Contraction Pathways—IL1B—Graves' disease	0.000302	0.00118	CbGpPWpGaD
Bepridil—CALM2—Myometrial Relaxation and Contraction Pathways—IL1B—Graves' disease	0.000302	0.00118	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—IL2RA—Graves' disease	0.000298	0.00116	CbGpPWpGaD
Bepridil—PDE1B—Innate Immune System—CD4—Graves' disease	0.000298	0.00116	CbGpPWpGaD
Bepridil—PDE1A—Immune System—IL2RA—Graves' disease	0.000298	0.00116	CbGpPWpGaD
Bepridil—PDE1A—Immune System—HLA-A—Graves' disease	0.000295	0.00115	CbGpPWpGaD
Bepridil—ABCB1—Allograft Rejection—TNF—Graves' disease	0.000295	0.00115	CbGpPWpGaD
Bepridil—PDE1B—Immune System—HLA-B—Graves' disease	0.000291	0.00114	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—HLA-E—Graves' disease	0.000278	0.00108	CbGpPWpGaD
Bepridil—PDE1B—Immune System—IL2RA—Graves' disease	0.000273	0.00106	CbGpPWpGaD
Bepridil—PDE1A—Disease—HLA-A—Graves' disease	0.000272	0.00106	CbGpPWpGaD
Bepridil—PDE1B—Immune System—HLA-A—Graves' disease	0.00027	0.00105	CbGpPWpGaD
Bepridil—CALM3—Metabolism—GC—Graves' disease	0.000269	0.00105	CbGpPWpGaD
Bepridil—PDE1A—Immune System—HLA-DRB1—Graves' disease	0.000269	0.00105	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—HLA-E—Graves' disease	0.000269	0.00105	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—HLA-E—Graves' disease	0.000269	0.00105	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—HLA-E—Graves' disease	0.000267	0.00104	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—CD40—Graves' disease	0.000261	0.00102	CbGpPWpGaD
Bepridil—CALM1—Metabolism—GC—Graves' disease	0.000261	0.00102	CbGpPWpGaD
Bepridil—CALM2—Metabolism—GC—Graves' disease	0.000261	0.00102	CbGpPWpGaD
Bepridil—PDE1A—Immune System—ICAM1—Graves' disease	0.000258	0.00101	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—HLA-E—Graves' disease	0.000258	0.00101	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—HLA-E—Graves' disease	0.000258	0.00101	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—CTLA4—Graves' disease	0.000257	0.001	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—CD40—Graves' disease	0.000252	0.000985	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—CD40—Graves' disease	0.000252	0.000985	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—CXCL10—Graves' disease	0.000252	0.000984	CbGpPWpGaD
Bepridil—PDE1B—Disease—HLA-A—Graves' disease	0.000249	0.000971	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—CTLA4—Graves' disease	0.000249	0.000971	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—CTLA4—Graves' disease	0.000249	0.000971	CbGpPWpGaD
Bepridil—PDE1B—Immune System—HLA-DRB1—Graves' disease	0.000246	0.000961	CbGpPWpGaD
Bepridil—CALM3—Disease—B3GNT2—Graves' disease	0.000244	0.000952	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—TSHR—Graves' disease	0.000239	0.000935	CbGpPWpGaD
Bepridil—PDE1B—Immune System—ICAM1—Graves' disease	0.000236	0.000922	CbGpPWpGaD
Bepridil—CALM1—Disease—B3GNT2—Graves' disease	0.000236	0.000921	CbGpPWpGaD
Bepridil—CALM2—Disease—B3GNT2—Graves' disease	0.000236	0.000921	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—TSHR—Graves' disease	0.000232	0.000904	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—TSHR—Graves' disease	0.000232	0.000904	CbGpPWpGaD
Bepridil—CACNA1D—Developmental Biology—TNF—Graves' disease	0.000232	0.000904	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—CXCL10—Graves' disease	0.000231	0.0009	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000212	0.000826	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—IL2RA—Graves' disease	0.000206	0.000804	CbGpPWpGaD
Bepridil—CALM3—Immune System—IFIH1—Graves' disease	0.000206	0.000803	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000205	0.000799	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000205	0.000799	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GC—Graves' disease	0.000204	0.000797	CbGpPWpGaD
Bepridil—CALM3—Metabolism—B3GNT2—Graves' disease	0.000204	0.000797	CbGpPWpGaD
Bepridil—CACNA1C—Developmental Biology—TNF—Graves' disease	0.000204	0.000795	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—IL2RA—Graves' disease	0.000199	0.000778	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—IL2RA—Graves' disease	0.000199	0.000778	CbGpPWpGaD
Bepridil—CALM2—Immune System—IFIH1—Graves' disease	0.000199	0.000777	CbGpPWpGaD
Bepridil—CALM1—Immune System—IFIH1—Graves' disease	0.000199	0.000777	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—HLA-B—Graves' disease	0.000198	0.000773	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—CD8A—Graves' disease	0.000198	0.000772	CbGpPWpGaD
Bepridil—CALM1—Metabolism—B3GNT2—Graves' disease	0.000198	0.000771	CbGpPWpGaD
Bepridil—CALM2—Metabolism—B3GNT2—Graves' disease	0.000198	0.000771	CbGpPWpGaD
Bepridil—PDE1A—Immune System—IFNG—Graves' disease	0.000197	0.000767	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—IL2RA—Graves' disease	0.000193	0.000752	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GC—Graves' disease	0.000192	0.000751	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—HLA-B—Graves' disease	0.000192	0.000748	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—HLA-B—Graves' disease	0.000192	0.000748	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—CD8A—Graves' disease	0.000191	0.000746	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—CD8A—Graves' disease	0.000191	0.000746	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—HLA-B—Graves' disease	0.00019	0.000742	CbGpPWpGaD
Bepridil—PDE1A—Immune System—CD4—Graves' disease	0.00019	0.000741	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—HLA-B—Graves' disease	0.000184	0.000718	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—HLA-B—Graves' disease	0.000184	0.000718	CbGpPWpGaD
Bepridil—PDE1B—Immune System—IFNG—Graves' disease	0.00018	0.000702	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—IL2RA—Graves' disease	0.000176	0.000688	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—HLA-A—Graves' disease	0.000176	0.000688	CbGpPWpGaD
Bepridil—PDE1A—Immune System—IL1B—Graves' disease	0.000175	0.000685	CbGpPWpGaD
Bepridil—PDE1A—Disease—CD4—Graves' disease	0.000175	0.000684	CbGpPWpGaD
Bepridil—PDE1B—Immune System—CD4—Graves' disease	0.000174	0.000678	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—HLA-A—Graves' disease	0.00017	0.000665	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—HLA-A—Graves' disease	0.00017	0.000665	CbGpPWpGaD
Bepridil—CALM3—Immune System—HLA-E—Graves' disease	0.000162	0.000632	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000161	0.000628	CbGpPWpGaD
Bepridil—PDE1B—Immune System—IL1B—Graves' disease	0.00016	0.000626	CbGpPWpGaD
Bepridil—PDE1B—Disease—CD4—Graves' disease	0.00016	0.000626	CbGpPWpGaD
Bepridil—CALM3—Immune System—CD40—Graves' disease	0.000158	0.000618	CbGpPWpGaD
Bepridil—CALM2—Immune System—HLA-E—Graves' disease	0.000157	0.000611	CbGpPWpGaD
Bepridil—CALM1—Immune System—HLA-E—Graves' disease	0.000157	0.000611	CbGpPWpGaD
Bepridil—CALM3—Immune System—CTLA4—Graves' disease	0.000156	0.000609	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000156	0.000608	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000156	0.000608	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—CXCL10—Graves' disease	0.000155	0.000604	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—B3GNT2—Graves' disease	0.000155	0.000604	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—ICAM1—Graves' disease	0.000154	0.000603	CbGpPWpGaD
Bepridil—CALM1—Immune System—CD40—Graves' disease	0.000153	0.000597	CbGpPWpGaD
Bepridil—CALM2—Immune System—CD40—Graves' disease	0.000153	0.000597	CbGpPWpGaD
Bepridil—CALM1—Immune System—CTLA4—Graves' disease	0.000151	0.000589	CbGpPWpGaD
Bepridil—CALM2—Immune System—CTLA4—Graves' disease	0.000151	0.000589	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—CXCL10—Graves' disease	0.00015	0.000584	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—CXCL10—Graves' disease	0.00015	0.000584	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—ICAM1—Graves' disease	0.000149	0.000583	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—ICAM1—Graves' disease	0.000149	0.000583	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—B3GNT2—Graves' disease	0.000146	0.000569	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.000145	0.000568	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TSHR—Graves' disease	0.000141	0.000552	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TSHR—Graves' disease	0.000137	0.000534	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TSHR—Graves' disease	0.000137	0.000534	CbGpPWpGaD
Bepridil—CALM3—Immune System—HLA-DQB1—Graves' disease	0.000128	0.000501	CbGpPWpGaD
Bepridil—CALM2—Immune System—HLA-DQB1—Graves' disease	0.000124	0.000485	CbGpPWpGaD
Bepridil—CALM1—Immune System—HLA-DQB1—Graves' disease	0.000124	0.000485	CbGpPWpGaD
Bepridil—CALM3—Immune System—CD8A—Graves' disease	0.00012	0.000468	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—IL2RA—Graves' disease	0.000118	0.000462	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—CD4—Graves' disease	0.000118	0.000461	CbGpPWpGaD
Bepridil—CALM2—Immune System—CD8A—Graves' disease	0.000116	0.000453	CbGpPWpGaD
Bepridil—CALM1—Immune System—CD8A—Graves' disease	0.000116	0.000453	CbGpPWpGaD
Bepridil—CALM3—Immune System—HLA-B—Graves' disease	0.000115	0.00045	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—IL2RA—Graves' disease	0.000114	0.000447	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—IL2RA—Graves' disease	0.000114	0.000447	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—CD4—Graves' disease	0.000114	0.000446	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—CD4—Graves' disease	0.000114	0.000446	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—CD4—Graves' disease	0.000114	0.000443	CbGpPWpGaD
Bepridil—CALM2—Immune System—HLA-B—Graves' disease	0.000112	0.000435	CbGpPWpGaD
Bepridil—CALM1—Immune System—HLA-B—Graves' disease	0.000112	0.000435	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—CD4—Graves' disease	0.00011	0.000429	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—CD4—Graves' disease	0.00011	0.000429	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL2RA—Graves' disease	0.000108	0.000422	CbGpPWpGaD
Bepridil—CALM3—Immune System—HLA-A—Graves' disease	0.000107	0.000417	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL2RA—Graves' disease	0.000105	0.000408	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL2RA—Graves' disease	0.000105	0.000408	CbGpPWpGaD
Bepridil—CALM2—Immune System—HLA-A—Graves' disease	0.000103	0.000403	CbGpPWpGaD
Bepridil—CALM1—Immune System—HLA-A—Graves' disease	0.000103	0.000403	CbGpPWpGaD
Bepridil—CALM3—Disease—HLA-A—Graves' disease	9.87e-05	0.000385	CbGpPWpGaD
Bepridil—CALM3—Immune System—HLA-DRB1—Graves' disease	9.76e-05	0.000381	CbGpPWpGaD
Bepridil—CALM1—Disease—HLA-A—Graves' disease	9.54e-05	0.000373	CbGpPWpGaD
Bepridil—CALM2—Disease—HLA-A—Graves' disease	9.54e-05	0.000373	CbGpPWpGaD
Bepridil—CALM2—Immune System—HLA-DRB1—Graves' disease	9.44e-05	0.000369	CbGpPWpGaD
Bepridil—CALM1—Immune System—HLA-DRB1—Graves' disease	9.44e-05	0.000369	CbGpPWpGaD
Bepridil—CALM3—Immune System—ICAM1—Graves' disease	9.37e-05	0.000366	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CXCL10—Graves' disease	9.14e-05	0.000357	CbGpPWpGaD
Bepridil—CALM1—Immune System—ICAM1—Graves' disease	9.06e-05	0.000354	CbGpPWpGaD
Bepridil—CALM2—Immune System—ICAM1—Graves' disease	9.06e-05	0.000354	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CXCL10—Graves' disease	8.84e-05	0.000345	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CXCL10—Graves' disease	8.84e-05	0.000345	CbGpPWpGaD
Bepridil—CALM3—Immune System—IFNG—Graves' disease	7.13e-05	0.000278	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL2RA—Graves' disease	6.99e-05	0.000273	CbGpPWpGaD
Bepridil—CALM1—Immune System—IFNG—Graves' disease	6.9e-05	0.000269	CbGpPWpGaD
Bepridil—CALM2—Immune System—IFNG—Graves' disease	6.9e-05	0.000269	CbGpPWpGaD
Bepridil—CALM3—Immune System—CD4—Graves' disease	6.89e-05	0.000269	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL2RA—Graves' disease	6.76e-05	0.000264	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL2RA—Graves' disease	6.76e-05	0.000264	CbGpPWpGaD
Bepridil—CALM2—Immune System—CD4—Graves' disease	6.66e-05	0.00026	CbGpPWpGaD
Bepridil—CALM1—Immune System—CD4—Graves' disease	6.66e-05	0.00026	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL1B—Graves' disease	6.36e-05	0.000248	CbGpPWpGaD
Bepridil—CALM3—Disease—CD4—Graves' disease	6.36e-05	0.000248	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL1B—Graves' disease	6.15e-05	0.00024	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL1B—Graves' disease	6.15e-05	0.00024	CbGpPWpGaD
Bepridil—CALM2—Disease—CD4—Graves' disease	6.15e-05	0.00024	CbGpPWpGaD
Bepridil—CALM1—Disease—CD4—Graves' disease	6.15e-05	0.00024	CbGpPWpGaD
